We are privileged to announce International Conference on Gastroenterology is scheduled during December 06-07 at Dubai, UAE. The scientific program of Gastroenterology 2021 creates an awareness about "Understanding Gastroenterology through a Multidisciplinary Approach” includes a wide range of Keynote presentations, Plenary talks, Video presentations, Symposia, Workshops, Exhibitions, Poster presentations, and e-posters.
World-renowned speakers, the most recent techniques, developments, and the newest updates in gastroenterology are the hallmarks of this conference. This gastroenterology conference will deliver a comprehensive overview of the latest information, insights and practices in gastroenterology, endoscopy, probiotics interaction, pancreatic diseases and more.
Session 01: Gastroenterology:
Gastroenterology is the study of the normal function and illnesses of the throat, stomach, small digestive tract, colon and rectum, pancreas, gallbladder, bile channels and liver. It includes a point by point study of the normal action (physiology) of the gastrointestinal organs including the movement of material through the stomach and digestive system (motility), the assimilation and retention of supplements into the body, expulsion of waste from the system, and the capacity of the liver as a digestive organ.
Session 02: Hepatology:
Hepatology is a branch of medicine concerned with the investigation, anticipation, analysis and administration of infections that influence the liver, gallbladder, biliary tree and pancreas. The term hepatology is gotten from the Greek words "hepatikos" and "logia," which mean liver and study, separately. Hepatitis influences a huge number of people internationally and is related with a few poor results including liver transplant and liver disease.
Session 03: Gastroenteritis & Hepatitis:
Gastroenteritis is an illness triggered by the infection and inflammation of the digestive system. The main complication of gastroenteritis is dehydration, but this can be prevented if the fluid lost in vomit and diarrhoea is replaced. Hepatitis is a contagious liver disease caused by the hepatitis virus. When a person is first infected with the virus, he or she can develop an “acute” (short-term) infection. Acute hepatitis B refers to the first 6 months after someone is infected with the hepatitis virus.
Session 04: Gastrointestinal Pathology & Radiology:
Gastrointestinal pathology (including liver, gallbladder and pancreas) is a recognized sub-specialty discipline of surgical pathology. Recognition of a sub-specialty is generally related to dedicated fellowship training offered within the subspecialty or, alternatively, to surgical pathologists with a special interest and extensive experience in gastrointestinal pathology. The most well-known finding is done through endoscopy. Radiology should be possible from various perspectives like x-beam, processed tomography, Magnetic reverberation imaging. Registered tomography permits extensive evaluation of stomach, pelvic provocative, irresistible cycles, deterrent, tumor location, show of vasculature, organizing and gruff injury impacts. Barium investigations of the gastrointestinal plot, enterocolitis for ordinary radiography and little inside evaluation actually have a part, notwithstanding the broad utilization of fiberoptic endoscopy. Fluoroscopy is significant, however extraordinary advances in advances have changed gastrointestinal radiology unavoidably.
Session 05: Gastrointestinal Drugs, Procedure and Treatment:
Medications used to treat depression, anxiety, and seizures have become increasingly attractive agents for use in functional gastrointestinal disorders because they act upon the central and peripheral nervous system to modulate mood, visceral, and neuropathic pain, as well as autonomic function, in part, through anticholinergic effects. The gastrointestinal sicknesses require treatment and the pharmacological treatments are partitioned into two classes the physician recommended drugs and Over the Counter (OTC Drugs).
Session 06: Digestive Disorders/ Gastroenterological Disorders:
Sickness happens when the primary anomaly is the way the body works. In the specialist's office, no basic or biochemical reason is seen. Gastrointestinal motility is characterized by the developments of the stomach related framework, and the travel of the substance inside it. Useful GI and motility issue, by and large, can't be analyzed generally. No incendiary, irresistible, or auxiliary anomaly can be seen by normally utilized examination, x-beam, or research center test. Diseases happen when nerves or muscles in any segment of the stomach related tract don't work in a planned manner, or when the affectability of the nerves of the digestion tracts or the route in which the cerebrum controls some of these capacities is hindered.
Session 07: Gastrointestinal Surgery:
Gastroenterology Surgery deals significantly with the stomach and gastro-intestinal tract. A general specialist manages focal center of life structures, immunology, concentrated care, digestion, neoplasia, nourishment, pathology, physiology, stun and revival, and wound recuperating. A general specialist is known to deal with the analysis of a condition, trailed by the pre-operative, operative, and the post-operative care, including complexities during surgery and post-surgery.
Session 08: Gastrointestinal Cancer:
Surgeons continue their efforts to improve their techniques to operate colorectal cancers. They now have a better understanding of what makes colorectal surgery more likely to be successful, such as making sure enough lymph nodes are removed during the operation. Treatments include surgery, chemotherapy, and radiation. Gallbladder cancer is a relatively uncommon cancer. If it is diagnosed early enough, it can be cured by removing the gallbladder, part of the liver and associated lymph nodes. Most often it is found after symptoms such as abdominal pain, jaundice and vomiting occur, and it has spread to other organs such as the liver.
Gastrointestinal Cancer Conferences | Abdominal & Primary Care Meet | Gastrointestinal Radiology Conferences | Gastrointestinal Immunology Summit | Esophageal and Gastric Disease Meet
Session 09: Gut Microbiome & Probiotics Interaction:
The gut microbiota is comprised of all the bacteria, commensal, and pathogenic, residing in the GIT. In the past decade the gut microbiota has been explored for potential gut microbe–host interactions including effects on metabolism, immune, and neuroendocrine responses. The gut microbiota plays an important role in nutrient and mineral absorption, synthesis of enzymes, vitamins and amino acids, and production of short-chain fatty acids (SCFAs). Probiotics are live microbes that, when administered in adequate amounts, have been shown to confer health benefits to the host. Over the years, probiotics have been a part of the human diet in the form of different fermented foods consumed around the world.
Gastroenterology Conferences | Gastrointestinal Surgery Summit | Digestive Disorders Conferences | Gastroenteritis Meet | Hepatology Summit
Session 10: Pancreatic Diseases:
It is an endocrine organ producing a few essential hormones, including insulin, glucagon, somatostatin, and pancreatic polypeptide, all of which flow in the blood. The pancreas is also a digestive organ, discharging pancreatic juice containing bicarbonate to neutralize acidity of chyme moving in from the stomach, and digestive enzymes that help assimilation and retention of supplements in the small intestine. There are a variety of disorders of the pancreas including:
Gastroenterology deals not just with the gastrointestinal issue or contaminations of the GI tract and adornment organs, yet in addition with the gastrointestinal treatments, medications, therapeutics, and gadgets that are utilized as a part of the diagnosing of the diseases and illnesses of the GI tract. As indicated by a current overview, 6 out of 10 individuals comprehensively, experience the ill effects of some type of the gastrointestinal issue at any given point in time. Fundamentally, the reasons for the commonness of the incessant stomach related and related sicknesses are because of way of life changes, absence of activity, overeating, sorrow, uneasiness, and financial and enthusiastic elements.
The gastrointestinal therapeutics market is expected to register a growth rate of about 5.8% over the forecast period, 2018 to 2023. The gastrointestinal (GI) complaints are common among infants, children, and adults, which results from the reflux of stomach contents into the esophagus. The therapeutic management of gastrointestinal diseases and symptoms is majorly through pharmaceutical interventions, whose market is driven by lifestyle changes leading to GI diseases and increasing R&D investments in biologics and biosimilars. As per the geographical analysis, Asia-Pacific has several emerging countries with increasing privatization which is anticipated to provide lucrative opportunities for global companies in this market, over the forecast period.
Gastrointestinal Therapeutics Market is Primarily Driven by Rapid Lifestyle Changes
For a large number of gastrointestinal disorders as well as related cancer lesions, the lifestyle changes and choices play a major role. In Asia, as per a 2015 study reported in Gastroenterology and Hepatology, the cancers related to GI system are most common in Asia Pacific region, particularly due to high alcohol and tobacco use among all age groups. In developed markets as well, a significantly large population is highly troubled with the GI diseases such as in the US, morbid obesity and lifestyle factors high affects a large population of the country. In Europe, United European Gastroenterology (UEG) recently welcomed an MEP Digestive Health Group in the European Parliament, their third annual digestive health month campaign to raise awareness regarding a range of chronic digestive diseases across Europe. Thus, over the forecast period, the lifestyle changes would be a significant factor to drive the gastrointestinal therapeutics market, globally.
Other driving factors include rising surgical treatments and hospitalizations due to GI diseases and increasing R&D investments by biopharmaceutical companies in developing biologics and biosimilars.
Increasing Socio-Economic Burden Associated with GI diseases Hinders the Growth of Gastrointestinal Therapeutics Market
The increasing acute GI diseases impose a great a burden socially and economically in low and middle-income countries. The distribution of gastrointestinal symptoms varies across social class and affects largely the population of low and middle-income countries. For example, the peptic ulcer disease is associated with low socioeconomic status. There are several studies reported across low and middle incomes countries where the low social class in the society has been linked to excess mortality from gastrointestinal diseases. Other factors such as physiological, behavioral, psychosocial, and socio-environmental risk factors, also restrict the populations from reporting the diseases early which reflects low awareness as well as an economic burden, restring the growth of the gastrointestinal therapeutics market.
Rising Economic Growth and Privatization in Medical Industry of Asia-Pacific Region Attracts High Growth Possibilities for Gastrointestinal Therapeutics Market
The Asian countries have shown the similar trend of growth in recent years as compared to western developed markets particularly owing to increasing economic growth along with privatization, competitive site experience, technological expertise, infrastructure, and scale to manage large-scale clinical trials across India, China, Japan, South Korea and others. The stomach related diseases have shown similar growth characteristics (incidence and prevalence) to western countries and thus the data of clinical trials are routinely accepted as part of US Food and Drug Administration (FDA) and European Medicines Agency (EMA) regulatory authorities. The unmet medical need and potential market opportunity have accelerated the partnerships with Asian pharmaceutical companies for development and commercial potential in the growth of the pharmaceutical business.
Market Growth of Gastroenterology Research:
The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.
The prescription therapies market is expected to grow from $18.6 billion in 2016 to nearly $22.1 billion in 2021 at a CAGR of 3.5% for the period 2016-2021.
The diagnostics market over the next five years will grow from $17.7 billion in 2016 to $23.5 billion in 2021 at a CAGR of 5.9% for the period 2016-2021.
The rise in the instances of Cohn’s disease, inflammatory bowel disease, ulcerative colitis, and such other diseases is also expected to create a rise in demand for the gastrointestinal diseases market. The growth in the demand and sale for the gastrointestinal drugs across the developing and developed markets is also attributed to be one of the major driving factors for this market. The growing investments and the research & development activities by the key market players are also expected to play a vital role in the overall growth of this market. The major restraining factors for the market include advancements in the new alternative therapies and the regulatory restraints.
Major Associations & Societies Associated with Gastroenterology in worldwide:
ASGE | American Society for Gastrointestinal Endoscopy
AGES | Indian Association of Gastrointestinal Endo Surgeons
SGNA | Society of Gastroenterology Nurses and Associates
ESGENA | The European Society of Gastroenterology and Endoscopy Nurses and Associates
Indian Association of Surgical Gastroenterology
American Society of Bariatric Physicians (ASBP)
National Association for Colitis and Crohn's Disease (NACC) (UK)
Crohn's & Colitis Foundation of America
Society of American Gastrointestinal and Endoscopic Surgeons
The Society of Gastroenterology Nurses and Associates
British Society of Gastroenterology (BSG)
The Bockus International Society of Gastroenterology
Major Universities associated with Gastroenterology in worldwide:
IBS The University of Barcelona
World Gastroenterology Organisation
American College of Gastroenterology
Medicine-Gastroenterology - University of Colorado
Pediatrics - Gastroenterology - Stanford Medicine - Stanford University
University of Pittsburgh
Division of Gastroenterology & Hepatology – University of Virginia
Gastroenterology and Hepatology: Department of Medicine: Feinberg
Division of Gastroenterology - McMaster University
Gastroenterology - Rush University Medical Center
Meetings International is announcing Young Scientist Awards through International Conference on Gastroenterology which is scheduled Dubai, UAE during December 06-07, 2021. This Gastroenterology Conference focuses on “Understanding Gastroenterology through a Multidisciplinary Approach”.
Gastroenterology 2021 and upcoming conferences will recognise participants who have significantly added value to the scientific community of gastroenterologists and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.
Gastroenterology 2021 focuses mainly the digestive tract and the gallbladder, liver, bile ducts, and pancreas. Gastroenterology conference operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.
Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. candidates. Persons from Scientific Industry can also participate.
The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.
Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT, and permission within the designated timeframe will result in forfeiture of award.
Official announcement of the recipients will occur after the completion of Gastroenterology Conference.
International Conference on Gastroenterology provides liability to all the global emirates to grow your business globally and sell your Research Materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, Instruments. Breathe life into your products and make moment brand mindfulness with a pennant advertisement arrangement. Make your pennant intuitive to guide individuals to where you need them to go.
Meetings International is providing opportunity to advertise and connect with the experts and leaders across the world. 3+ Million Website Visitors, 40000+ Conference Website Visitors and 1000+ Sessions which confirm the outstanding pool of new users and visitors creating a platform to build your market place globally. Meetings International helps you to connect with global clients anywhere at any time via our unrivalled, worldwide professionals reach. Start promoting your brand today, basically browse our immense scope of custom fitted, multi-channel publicizing and sponsorship alternatives across print and computerized stages and select the geology of your intended interest group.
We maintain high quality and ethical standards in event industry, which makes us unique and better than the rest. Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.
Ping us your interests via WhatsApp: +65 3158 1626
Learning In a New Space
New Tips & Tactics